220 related articles for article (PubMed ID: 25329465)
21. Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells.
You H; Jin J; Shu H; Yu B; De Milito A; Lozupone F; Deng Y; Tang N; Yao G; Fais S; Gu J; Qin W
Cancer Lett; 2009 Jul; 280(1):110-9. PubMed ID: 19299075
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the V-ATPase by Archazolid A: A New Strategy to Inhibit EMT.
Merk H; Messer P; Ardelt MA; Lamb DC; Zahler S; Müller R; Vollmar AM; Pachmayr J
Mol Cancer Ther; 2017 Nov; 16(11):2329-2339. PubMed ID: 28775146
[TBL] [Abstract][Full Text] [Related]
23. Myrtenal-induced V-ATPase inhibition - A toxicity mechanism behind tumor cell death and suppressed migration and invasion in melanoma.
Martins BX; Arruda RF; Costa GA; Jerdy H; de Souza SB; Santos JM; de Freitas WR; Kanashiro MM; de Carvalho ECQ; Sant'Anna NF; Antunes F; Martinez-Zaguilan R; Souad S; Okorokova-Façanha AL; Façanha AR
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):1-12. PubMed ID: 30279148
[TBL] [Abstract][Full Text] [Related]
24. Enhanced lysosomal activity is involved in Bax inhibitor-1-induced regulation of the endoplasmic reticulum (ER) stress response and cell death against ER stress: involvement of vacuolar H+-ATPase (V-ATPase).
Lee GH; Kim DS; Kim HT; Lee JW; Chung CH; Ahn T; Lim JM; Kim IK; Chae HJ; Kim HR
J Biol Chem; 2011 Jul; 286(28):24743-53. PubMed ID: 21586565
[TBL] [Abstract][Full Text] [Related]
25. MI-63: a novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53.
Canner JA; Sobo M; Ball S; Hutzen B; DeAngelis S; Willis W; Studebaker AW; Ding K; Wang S; Yang D; Lin J
Br J Cancer; 2009 Sep; 101(5):774-81. PubMed ID: 19707204
[TBL] [Abstract][Full Text] [Related]
26. Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
Nakahata K; Uehara S; Nishikawa S; Kawatsu M; Zenitani M; Oue T; Okuyama H
PLoS One; 2015; 10(4):e0125454. PubMed ID: 25915760
[TBL] [Abstract][Full Text] [Related]
27. Proton pumping V-ATPase inhibitor bafilomycin A1 affects Rab7 lysosomal localization and abolishes anterograde trafficking of osteoclast secretory lysosomes.
Matsumoto N; Nakanishi-Matsui M
Biochem Biophys Res Commun; 2019 Mar; 510(3):421-426. PubMed ID: 30717974
[TBL] [Abstract][Full Text] [Related]
28. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
[TBL] [Abstract][Full Text] [Related]
29. Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition.
Hraběta J; Belhajová M; Šubrtová H; Merlos Rodrigo MA; Heger Z; Eckschlager T
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575682
[TBL] [Abstract][Full Text] [Related]
30. D,L-Methadone enhances the cytotoxic activity of standard chemotherapeutic agents on pediatric rhabdomyosarcoma.
Urla C; Corteletti I; Raible AS; Handgretinger R; Fuchs J; Warmann SW; Schmid E
J Cancer Res Clin Oncol; 2022 Jun; 148(6):1337-1350. PubMed ID: 35182225
[TBL] [Abstract][Full Text] [Related]
31. Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes.
Abu-Remaileh M; Wyant GA; Kim C; Laqtom NN; Abbasi M; Chan SH; Freinkman E; Sabatini DM
Science; 2017 Nov; 358(6364):807-813. PubMed ID: 29074583
[TBL] [Abstract][Full Text] [Related]
32. Silencing of vacuolar ATPase c subunit ATP6V0C inhibits the invasion of prostate cancer cells through a LASS2/TMSG1-independent manner.
Zou P; Yang Y; Xu X; Liu B; Mei F; You J; Liu Q; Pei F
Oncol Rep; 2018 Jan; 39(1):298-306. PubMed ID: 29138865
[TBL] [Abstract][Full Text] [Related]
33. Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking.
O'Callaghan KM; Ayllon V; O'Keeffe J; Wang Y; Cox OT; Loughran G; Forgac M; O'Connor R
J Biol Chem; 2010 Jan; 285(1):381-91. PubMed ID: 19875448
[TBL] [Abstract][Full Text] [Related]
34. V-ATPase as an effective therapeutic target for sarcomas.
Perut F; Avnet S; Fotia C; Baglìo SR; Salerno M; Hosogi S; Kusuzaki K; Baldini N
Exp Cell Res; 2014 Jan; 320(1):21-32. PubMed ID: 24416789
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells.
Megiorni F; Gravina GL; Camero S; Ceccarelli S; Del Fattore A; Desiderio V; Papaccio F; McDowell HP; Shukla R; Pizzuti A; Beirinckx F; Pujuguet P; Saniere L; der Aar EV; Maggio R; De Felice F; Marchese C; Dominici C; Tombolini V; Festuccia C; Marampon F
J Hematol Oncol; 2017 Oct; 10(1):161. PubMed ID: 28985758
[TBL] [Abstract][Full Text] [Related]
36. Dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 synergizes with chloroquine to induce apoptosis in embryonal rhabdomyosarcoma.
Hugle M; Fulda S
Cancer Lett; 2015 Apr; 360(1):1-9. PubMed ID: 25637161
[TBL] [Abstract][Full Text] [Related]
37. Lysosome and lysosome-related organelles responsible for specialized functions in higher organisms, with special emphasis on vacuolar-type proton ATPase.
Sun-Wada GH; Wada Y; Futai M
Cell Struct Funct; 2003 Oct; 28(5):455-63. PubMed ID: 14745137
[TBL] [Abstract][Full Text] [Related]
38. Artesunate induces ROS- and p38 MAPK-mediated apoptosis and counteracts tumor growth in vivo in embryonal rhabdomyosarcoma cells.
Beccafico S; Morozzi G; Marchetti MC; Riccardi C; Sidoni A; Donato R; Sorci G
Carcinogenesis; 2015 Sep; 36(9):1071-83. PubMed ID: 26153023
[TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitors may reduce tumour resistance.
De Milito A; Fais S
Expert Opin Pharmacother; 2005 Jun; 6(7):1049-54. PubMed ID: 15957961
[TBL] [Abstract][Full Text] [Related]
40. Activity of plasma membrane V-ATPases is critical for the invasion of MDA-MB231 breast cancer cells.
Cotter K; Capecci J; Sennoune S; Huss M; Maier M; Martinez-Zaguilan R; Forgac M
J Biol Chem; 2015 Feb; 290(6):3680-92. PubMed ID: 25505184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
